RobertSokolicMDFACP(He/Him)
Oncology • Silver Spring, MDHematologic Oncology
Medical Officer, CBER, FDA
Dr. Sokolic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20903
Summary
- Hematologist-oncologist with clinical, research, industry and regulatory experience in cell and gene therapy for hematologic malignancies, solid tumors, sickle cell disease, primary immunodeficiencies, storage disorders and rare diseases
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2002
University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1998
The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
RI State Medical License 2017 - 2026
NY State Medical License 1998 - 2025
CT State Medical License 2023 - 2024
DC State Medical License 2017 - 2018
MD State Medical License 2015 - 2017
PA State Medical License 1997 - 1998- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Molecular and Clinical Studies of Primary Immunodeficiency Diseases Start of enrollment: 2000 Oct 25
- Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency Start of enrollment: 2001 Jun 20
- Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents Start of enrollment: 2010 Aug 05
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsAutologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.Donald B. Kohn, Claire Booth, Kit L. Shaw, Jinhua Xu-Bayford, Elizabeth Garabedian
The New England Journal of Medicine. 2021-05-11 - 183 citationsThe altered landscape of the human skin microbiome in patients with primary immunodeficienciesJulia Oh, Alexandra F. Freeman, Nisc Comparative Sequencing Program, Morgan Park, Robert A. Sokolic
Genome Research. 2013-12-01 - 583 citationsActionable Diagnosis of Neuroleptospirosis by Next-Generation SequencingMichael R. Wilson, Samia N. Naccache, Erik Samayoa, Mark Biagtan, Hiba Bashir
The New England Journal of Medicine. 2014-06-18
Professional Memberships
- Fellow
- Member
- Member
- Member
- American Society of Blood and Marrow TransplantationMember
- American Society of Cell and Gene TherapyMember
- Clinical Immunology SocietyMember
- European Society for Immune DeficiencyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
